Functional correlates of NT-proBNP reduction in response to chemotherapy in cardiac AL amyloidosis

被引：0
|
作者：
Perlini, S. [1 ]
Salinaro, F. [1 ]
Musca, F. [1 ]
Fracchioni, I. [1 ]
Palladini, G. [1 ,3 ]
Albertini, R. [2 ]
Moratti, R. [2 ]
Palladini, G. [1 ,3 ]
Rapezzi, C. [4 ]
Merlini, G. [3 ]
机构：
[1] Univ Pavia, Med Clin 2, Fondaz IRCCS S Matteo, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy
[3] Biotechnol Labs IRCCS San Matteo, Ctr Amyloidosis, Pavia, Italy
[4] Univ Hosp Polyclin San Orsola Malpighi, Dept Cardiol, Bologna, Italy
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [41] Cardiac Function and NT-proBNP Levels Before and After Childbirth
    Yasuyo, Takeuchi
    Wakabayashi, Yasushi
    Ootani, Hayato
    Takeuchi, Kazuhiko
    Watanabe, Hiroshi
    HYPERTENSION, 2011, 58 (05) : E113 - E113
  • [42] RED CELL DISTRIBUTION WIDTH CORRELATES WITH NT-PROBNP IN PULMONARY HYPERTENSION
    Todhe, Pandi
    Sharma, Nishant
    Ravi, Divya
    Haider, Syed
    Sravanthi, Metlapalli Venkata
    Ochieng, Pius
    CHEST, 2020, 158 (04) : 2199A - 2199A
  • [43] NT-proBNP concentrations indicate cardiac disease in pediatric patients
    Geiger, Ralf
    Hammerer-Lercher, Angelika
    Url, Christoph
    Schweigmann, Ulrich
    Puschendorf, Bernd
    Sommer, Rudolf
    Stein, Joerg Ingolf
    Mair, Johannes
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 123 (01) : 63 - 65
  • [44] Influence of dialysis parameters on cardiac biomarkers cTNT and NT-proBNP
    Sommerer, Claudia
    Heckele, Nadine
    Katus, Hugo A.
    Giannitsis, Evangelos
    Zeier, Martin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 471 - 472
  • [45] The prognostic significance of nt-proBNP in patients undergoing cardiac surgery
    Cuthbertson, B. H.
    Croal, B. L.
    McNeilly, J. D.
    Gibson, P.
    Rae, D.
    Jeffrey, R.
    Buchan, K.
    Gibson, G.
    El-Shafei, H.
    Hillis, G. S.
    CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 183 - 184
  • [46] Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design
    Vaxman, I.
    Kumar, S. K.
    Buadi, F.
    Lacy, M. Q.
    Dingli, D.
    Hwa, Y.
    Fonder, A.
    Hobbs, M.
    Hayman, S.
    Kourelis, T.
    Warsame, R.
    Muchtar, E.
    Leung, N.
    Kapoor, P.
    Grogan, M.
    Go, R.
    Lin, Y.
    Gonsalves, W.
    Siddiqui, M.
    Kyle, R. A.
    Rajkumar, S. V.
    Gertz, M. A.
    Dispenzieri, A.
    LEUKEMIA, 2021, 35 (12) : 3604 - 3607
  • [47] NT-Probnp As Personalized Medicine Tool and New Biomarker Predicting Response to Chemotherapy and Survival in AML
    Graf, Irene
    Greiner, Georg
    Marculescu, Rodrig
    Gleixner, Karoline V.
    Herndlhofer, Susanne
    Stefanzl, Gabriele
    Knoebl, Paul
    Jaeger, Ulrich
    Hauswirth, Alexander
    Schwarzinger, Ilse
    Thalhammer, Renate
    Kundi, Michael
    Hoermann, Gregor
    Mitterbauer-Hohendanner, Gerlinde
    Valent, Peter
    Sperr, Wolfgang R.
    BLOOD, 2021, 138
  • [48] NT-proBNP: A marker of preclinical cardiac damage in arterial hypertension
    Di Stasio, Enrico
    Russo, Andrea
    Mettimano, Marco
    Viviani, Domenico
    Scagliusi, Alessandro
    Bruno, Antonio
    Giuliani, Alessandro
    Isgro, Maria Antonietta
    Romitelli, Federica
    Savi, Luigi
    CLINICA CHIMICA ACTA, 2011, 412 (11-12) : 1106 - 1111
  • [49] Prognostic implications of baseline NT-proBNP before cardiac surgery
    Palazuelos, Jorge
    Rubio Alonso, Miguel Angel
    Clares Monton, Patricia
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (01): : 252 - 253
  • [50] Nt-proBNP as a diagnostic marker of cardiac geometry in essential hypertension
    Mettimano, M.
    Russo, A.
    Bruno, A.
    Giuliani, A.
    Di Stasio, E.
    Zuppi, C.
    Savi, L.
    JOURNAL OF HYPERTENSION, 2006, 24 : S117 - S117
12345